welcome to the video journal of hematology & hematological oncology 🎥🩸
Published 1 month ago • 328 plays • Length 3:08Download video MP4
Download video MP3
Similar videos
-
5:15
outlook on the current car-t climate
-
1:38
the future of car-t for hematological malignancies and solid tumors
-
0:56
the current advantages and limitations of nk-cell-based therapies
-
1:20
the current standard of care for patients with lower-risk mds
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
53:13
what is the difference between health-related quality of life (hrqol) and patient-reported outcomes?
-
5:09
what do you see as the future of aml treatments? #aml
-
8:11
current car-t climate in multiple myeloma
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
4:12
opportunities to improve car-t outcomes
-
1:15
car-t therapy: where is it going?
-
8:57
outcomes of sct in t-all and t-lbl
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
2:16
current and future treatment approaches for hr-mds
-
2:41
an overview of the latest advances in hematology
-
2:42
the benefits of the european car t-cell meeting to young investigators
-
1:26
the impact of covid-19 on car-t therapy
-
1:17
nk-car immunotherapy: the next steps
-
2:44
car-t: driving the field
-
6:51
role of the ebmt registry on reporting car t-cell outcomes